2023年

英文

Genome-wide association studies in advanced prostate cancer: KYUCOG-1401-A study.

Shiota M, Tatarano S, Kamoto T, Matsuyama H, Sakai H, Igawa T, Kamba T, Fujimoto N, Sekine Y, Kimura H, Narita S, Terada N, Momozawa Y, Akamatsu S, Habuchi T, Yokomizo A, Naito S, Eto M.

Endocr Relat Cancer. 2023 Apr 1:ERC-23-0044. doi: 10.1530/ERC-23-0044. Online ahead of print. PMID: 37079309

 

Predictive value of CXCL10 for the occurrence of immune-related adverse events in patient with renal cell carcinoma.

Miura Y, Motoshima T, Anami T, Yano H, Mito R, Pan C, Urakami S, Kinowaki K, Tsukamoto H, Kurahashi R, Murakami Y, Yatsuda J, Fujiwara Y, Kamba T, Komohara Y.

Microbiol Immunol. 2023 Mar 28. doi: 10.1111/1348-0421.13067. Online ahead of print. PMID: 36975091

 

Effect of genetic polymorphisms on outcomes following nivolumab for advanced renal cell carcinoma in the SNiP-RCC trial.

Shiota M, Miyake H, Takahashi M, Oya M, Tsuchiya N, Masumori N, Matsuyama H, Obara W, Shinohara N, Fujimoto K, Nozawa M, Ohba K, Ohyama C, Hashine K, Akamatsu S, Kamba T, Mita K, Gotoh M, Tatarano S, Fujisawa M, Tomita Y, Mukai S, Ito K, Tanegashima T, Tokunaga S, Eto M.

Cancer Immunol Immunother. 2023 Feb 2. Doi: 10.1007/s00262-023-03367-w. Online ahead of print. PMID: 36729213

 

Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasis.

Nakamura K, Norihisa Y, Ikeda I, Inokuchi H, Aizawa R, Kamoto T, Kamba T, Inoue T, Yamasaki T, Akamatsu S, Kobayashi T, Ogawa O, Mizowaki T.

Cancer Med. 2023;12(7):7859-7867.

 

Sicca syndrome during ipilimumab and nivolumab therapy for metastatic renal cell carcinoma.

Segawa T, Motoshima T, Yatsuda J, Kurahashi R, Fukushima Y, Murakami Y, Yamaguchi T, Sugiyama Y, Yoshida R, Nakayama H, Kamba T.

IJU Case Rep. 2023;6(2):147-149.

 

The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

Terada N, Sawada A, Kawanishi H, Fujimoto T, Magaribuchi T, Chihara I, Hashimoto K, Sakurai T, Shimizu Y, Uegaki M, Nakashima M, Narita S, Kubota M, Yamada Y, Tohi Y, Okabe K, Yatsuda J, Kamoto T.

Int J Urol. 2023;30(2):227-234.

 

Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study.

Tsuzuki T, Ohe C, Osawa T, Yasuda Y, Tanaka T, Anai S, Kimura G, Yamana K, Hatakeyama S, Yoshimoto T, Nakagawa Y, Fukuyama T, Matsubara N, Uemura H.

(Motoshima Takanobu is indicated in List of Investigators, Supplementary Appendix.)

Pathology. 2023;55(1):31-39.

 

和文

ロボット支援腹腔鏡下前立腺全摘除術におけるポートサイトヘルニアへの予防的措置の実践

倉橋竜磨, 脊川卓也,元島崇信,村上洋嗣,矢津田旬二,杉山豊,神波大己

Jpn J Endurol Robot. 2023;36(1):146-150.